• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先进的微流控血管化组织作为研究人类疾病和药物开发的平台。

Advanced Microfluidic Vascularized Tissues as Platform for the Study of Human Diseases and Drug Development.

机构信息

Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, 79106, USA.

Department of Biological and Biomedical Sciences, Oakland University, Rochester, MI 48309, USA.

出版信息

Curr Neuropharmacol. 2023;21(3):599-620. doi: 10.2174/1570159X20666220706112711.

DOI:10.2174/1570159X20666220706112711
PMID:35794768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10207903/
Abstract

The vascular system plays a critical role in human physiology and diseases. It is a complex subject to study using in vitro models due to its dynamic and three-dimensional microenvironment. Microfluidic technology has recently become a popular technology in various biological fields for its advantages in mimicking complex microenvironments to an extent not achievable by more conventional platforms. Microfluidic technologies can reproduce different vascular system-related structures and functions that can be utilized for drug development and human diseases studies. Herein, we first review the relevant structural and functional vascular biology systems of various organ systems and then the fabrication methods to reproduce these vascular districts. We provide a thorough review of the latest achievement in vascular organ-on-chip modeling specific to lung, heart, and the brain microvasculature for drug screening and the study of human disorders.

摘要

血管系统在人体生理学和疾病中起着至关重要的作用。由于其动态和三维微环境,使用体外模型研究这一系统具有挑战性。微流控技术最近在各种生物领域成为一种流行的技术,因为它具有模拟复杂微环境的优势,而这是更传统平台无法实现的。微流控技术可以复制不同的与血管系统相关的结构和功能,可用于药物开发和人类疾病研究。在此,我们首先综述了各种器官系统的相关结构和功能血管生物学系统,然后介绍了复制这些血管区域的制造方法。我们全面综述了用于药物筛选和人类疾病研究的肺、心脏和脑微血管的血管器官芯片建模方面的最新成果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/d39f93641605/CN-21-599_F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/7aea1d50b4cf/CN-21-599_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/01d9819266f7/CN-21-599_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/c09fdf635ef3/CN-21-599_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/5976eab24f41/CN-21-599_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/9f788d99b93c/CN-21-599_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/9157275181ae/CN-21-599_F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/d39f93641605/CN-21-599_F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/7aea1d50b4cf/CN-21-599_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/01d9819266f7/CN-21-599_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/c09fdf635ef3/CN-21-599_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/5976eab24f41/CN-21-599_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/9f788d99b93c/CN-21-599_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/9157275181ae/CN-21-599_F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc3b/10207903/d39f93641605/CN-21-599_F7.jpg

相似文献

1
Advanced Microfluidic Vascularized Tissues as Platform for the Study of Human Diseases and Drug Development.先进的微流控血管化组织作为研究人类疾病和药物开发的平台。
Curr Neuropharmacol. 2023;21(3):599-620. doi: 10.2174/1570159X20666220706112711.
2
Vascularized microfluidic platforms to mimic the tumor microenvironment.血管化微流控平台模拟肿瘤微环境。
Biotechnol Bioeng. 2018 Nov;115(11):2793-2806. doi: 10.1002/bit.26778. Epub 2018 Sep 6.
3
Microfluidics-based in vivo mimetic systems for the study of cellular biology.用于细胞生物学研究的基于微流控的体内模拟系统。
Acc Chem Res. 2014 Apr 15;47(4):1165-73. doi: 10.1021/ar4002608. Epub 2014 Feb 20.
4
Microfluidic bioprinting for organ-on-a-chip models.微流控生物打印在器官芯片模型中的应用。
Drug Discov Today. 2019 Jun;24(6):1248-1257. doi: 10.1016/j.drudis.2019.03.025. Epub 2019 Mar 30.
5
Microfluidic systems for modeling digestive cancer: a review of recent progress.用于模拟消化道癌症的微流控系统:近期进展综述。
Biomed Phys Eng Express. 2024 Aug 28;10(5). doi: 10.1088/2057-1976/ad6f15.
6
Next generation human skin constructs as advanced tools for drug development.下一代人造皮肤构建体作为药物开发的先进工具。
Exp Biol Med (Maywood). 2017 Nov;242(17):1657-1668. doi: 10.1177/1535370217712690. Epub 2017 Jun 7.
7
Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development.微流控器官芯片系统用于疾病建模和药物开发。
Biosensors (Basel). 2022 May 27;12(6):370. doi: 10.3390/bios12060370.
8
Skin Diseases Modeling using Combined Tissue Engineering and Microfluidic Technologies.利用组织工程与微流控技术进行皮肤病建模。
Adv Healthc Mater. 2016 Oct;5(19):2459-2480. doi: 10.1002/adhm.201600439. Epub 2016 Aug 22.
9
Fabrication of Biomaterials and Biostructures Based On Microfluidic Manipulation.基于微流控操作的生物材料与生物结构制造
Small. 2022 Apr;18(16):e2105867. doi: 10.1002/smll.202105867. Epub 2022 Jan 24.
10
Engineering Tissue Barrier Models on Hydrogel Microfluidic Platforms.在水凝胶微流控平台上构建组织屏障模型。
ACS Appl Mater Interfaces. 2021 Mar 31;13(12):13920-13933. doi: 10.1021/acsami.0c21573. Epub 2021 Mar 19.

引用本文的文献

1
Vascularized platforms for investigating cell communication via extracellular vesicles.用于通过细胞外囊泡研究细胞通讯的血管化平台
Biomicrofluidics. 2024 Sep 23;18(5):051504. doi: 10.1063/5.0220840. eCollection 2024 Sep.
2
Revolutionizing neurotherapeutics: blood-brain barrier-on-a-chip technologies for precise drug delivery.革新神经治疗学:用于精准药物递送的芯片上血脑屏障技术
Ann Med Surg (Lond). 2024 Mar 4;86(5):2794-2804. doi: 10.1097/MS9.0000000000001887. eCollection 2024 May.

本文引用的文献

1
Engineering organ-on-a-chip systems to model viral infections.工程化器官芯片系统以模拟病毒感染。
Biofabrication. 2023 Feb 6;15(2). doi: 10.1088/1758-5090/ac6538.
2
Engineering neurovascular organoids with 3D printed microfluidic chips.利用3D打印微流控芯片构建神经血管类器官
Lab Chip. 2022 Apr 12;22(8):1615-1629. doi: 10.1039/d1lc00535a.
3
A Quasi-Physiological Microfluidic Blood-Brain Barrier Model for Brain Permeability Studies.用于脑通透性研究的准生理微流控血脑屏障模型
Pharmaceutics. 2021 Sep 15;13(9):1474. doi: 10.3390/pharmaceutics13091474.
4
Microfluidic device with brain extracellular matrix promotes structural and functional maturation of human brain organoids.微流控装置与脑细胞外基质促进人脑类器官的结构和功能成熟。
Nat Commun. 2021 Aug 5;12(1):4730. doi: 10.1038/s41467-021-24775-5.
5
Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review.肺微生理系统在COVID-19建模和药物发现中的应用:综述
Biodes Manuf. 2021;4(4):757-775. doi: 10.1007/s42242-021-00136-5. Epub 2021 Jun 18.
6
Second-generation lung-on-a-chip with an array of stretchable alveoli made with a biological membrane.第二代肺芯片,带有由生物膜制成的可拉伸肺泡阵列。
Commun Biol. 2021 Feb 5;4(1):168. doi: 10.1038/s42003-021-01695-0.
7
A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity.血脑屏障的结构、功能、损伤及完整性生物标志物概述。
Fluids Barriers CNS. 2020 Nov 18;17(1):69. doi: 10.1186/s12987-020-00230-3.
8
SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids.SARS-CoV-2 感染人脑类器官的脉络丛并破坏血脑屏障。
Cell Stem Cell. 2020 Dec 3;27(6):951-961.e5. doi: 10.1016/j.stem.2020.10.001. Epub 2020 Oct 13.
9
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.SARS-CoV-2 刺突蛋白改变了二维静态和三维微流控体外血脑屏障模型中的屏障功能。
Neurobiol Dis. 2020 Dec;146:105131. doi: 10.1016/j.nbd.2020.105131. Epub 2020 Oct 11.
10
SARS-CoV-2 targets neurons of 3D human brain organoids.SARS-CoV-2 靶向 3D 人脑组织类器官中的神经元。
EMBO J. 2020 Oct 15;39(20):e106230. doi: 10.15252/embj.2020106230. Epub 2020 Sep 23.